Your Health Plan:
Your Health Plan:
Not SelectedTAKHZYRO (lanadelumab) is a biologic prescription drug for treatment of Angioedemas, Hereditary. TAKHZYRO is a plasma kallikrein inhibitor. It is available in the form of subcutaneous solution / subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $11100-34200.